Vontobel Holding
RPTX

Vontobel Holding’s Repare Therapeutics RPTX Stock Holding History

Vontobel Holding’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,000
Closed -$70.4K – 1513
2025
Q3 		$70.4K Hold
40,000
– – ﹤0.01% 1308
2025
Q2 		$55.6K Hold
40,000
– – ﹤0.01% 1230
2025
Q1 		$39.4K Buy
40,000
+5,000
+14% +$6.03K ﹤0.01% 1070
2024
Q4 		$45.9K Buy
35,000
+11,000
+46% +$32.8K ﹤0.01% 1081
2024
Q3 		$82.6K Buy
24,000
+4,000
+20% +$13.2K ﹤0.01% 1039
2024
Q2 		$66K Buy
20,000
+5,000
+33% +$17.8K ﹤0.01% 1034
2024
Q1 		$70.7K Hold
15,000
– – ﹤0.01% 1041
2023
Q4 		$110K Buy
+15,000
New +$83.9K ﹤0.01% 1037

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vontobel Holding's RPTX Position: Q4 2025 in Review

Vontobel Holding sold out of Repare Therapeutics (RPTX) in Q4 2025, closing a stake of 40,000 shares — an estimated $70.4K sold.

Vontobel Holding first reported a position in RPTX in Q4 2023 and held it in 8 quarters. The position peaked at $110K in Q4 2023. 46 funds tracked by Wall St. Rank hold RPTX as of Q4 2025.

  • Vontobel Holding reported no remaining Repare Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Vontobel Holding sold 40,000 Repare Therapeutics shares in Q4 2025, an estimated $70.4K.
  • Vontobel Holding first reported a position in Repare Therapeutics in Q4 2023 and held it in 8 quarters.
  • Vontobel Holding's Repare Therapeutics position peaked at $110K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2025.

Based on Vontobel Holding's 13F filing for Q4 2025, filed 13 Feb 2026.